{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:18:24Z","timestamp":1792124304371,"version":"4.4.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,4]],"date-time":"2019-05-04T00:00:00Z","timestamp":1556928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Paul D. Wellstone Muscular Dystrophy Cooperative Research Center","award":["1U54NS053672"],"award-info":[{"award-number":["1U54NS053672"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Skeletal Muscle"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13395-019-0195-0","type":"journal-article","created":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T10:26:16Z","timestamp":1557138376000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Exogenous expression of the glycosyltransferase LARGE1 restores \u03b1-dystroglycan matriglycan and laminin binding in rhabdomyosarcoma"],"prefix":"10.1186","volume":"9","author":[{"given":"Daniel","family":"Beltr\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendra","family":"Bharathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teagan P.","family":"Settelmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew N.","family":"Svalina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zia","family":"Bajwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Shern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakir H.","family":"Gultekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco A.","family":"Cuellar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Yonekawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2066-5889","authenticated-orcid":false,"given":"Kevin P.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,4]]},"reference":[{"issue":"Pt 2","key":"195_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1242\/jcs.02814","volume":"119","author":"R Barresi","year":"2006","unstructured":"Barresi R, Campbell KP. Dystroglycan: from biosynthesis to pathogenesis of human disease. J Cell Sci. 2006;119(Pt 2):199\u2013207.","journal-title":"J Cell Sci"},{"issue":"3","key":"195_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0959-437X(02)00309-X","volume":"12","author":"M Durbeej","year":"2002","unstructured":"Durbeej M, Campbell KP. Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr Opin Genet Dev. 2002;12(3):349\u201361.","journal-title":"Curr Opin Genet Dev"},{"issue":"38","key":"195_CR3","doi-asserted-by":"publisher","first-page":"23418","DOI":"10.1074\/jbc.271.38.23418","volume":"271","author":"H Yamada","year":"1996","unstructured":"Yamada H, Denzer AJ, Hori H, Tanaka T, Anderson LV, Fujita S, et al. Dystroglycan is a dual receptor for agrin and laminin-2 in Schwann cell membrane. J Biol Chem. 1996;271(38):23418\u201323.","journal-title":"J Biol Chem"},{"issue":"7","key":"195_CR4","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.cell.2004.06.003","volume":"117","author":"M Kanagawa","year":"2004","unstructured":"Kanagawa M, Saito F, Kunz S, Yoshida-Moriguchi T, Barresi R, Kobayashi YM, et al. Molecular recognition by LARGE is essential for expression of functional dystroglycan. Cell. 2004;117(7):953\u201364.","journal-title":"Cell."},{"issue":"2","key":"195_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1083\/jcb.200104103","volume":"155","author":"S Kunz","year":"2001","unstructured":"Kunz S, Sevilla N, McGavern DB, Campbell KP, Olstone MB. Molecular analysis of the interaction of LCMV with its cellular receptor \u03b1-dystroglycan. J Cell Biol. 2001;155(2):301\u201310.","journal-title":"J Cell Biol"},{"issue":"5","key":"195_CR6","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/0092-8674(94)90052-3","volume":"77","author":"SH Gee","year":"1994","unstructured":"Gee SH, Montanaro F, Lindenbaum MH, Carbonetto S. Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor. Cell. 1994;77(5):675\u201386.","journal-title":"Cell."},{"issue":"4","key":"195_CR7","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/emboj\/18.4.863","volume":"18","author":"JF Talts","year":"1999","unstructured":"Talts JF, Andac Z, Gohring W, Brancaccio A, Timpl R. Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins. EMBO J. 1999;18(4):863\u201370.","journal-title":"EMBO J"},{"issue":"5","key":"195_CR8","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.neuron.2012.10.009","volume":"76","author":"KM Wright","year":"2012","unstructured":"Wright KM, Lyon KA, Leung H, Leahy DJ, Ma L, Ginty DD. Dystroglycan organizes axon guidance cue localization and axonal pathfinding. Neuron. 2012;76(5):931\u201344.","journal-title":"Neuron."},{"issue":"3","key":"195_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0898-6568(01)00236-4","volume":"14","author":"JL Ilsley","year":"2002","unstructured":"Ilsley JL, Sudol M, Winder SJ. The WW domain: linking cell signalling to the membrane cytoskeleton. Cell Signal. 2002;14(3):183\u20139.","journal-title":"Cell Signal"},{"issue":"20","key":"195_CR10","doi-asserted-by":"publisher","first-page":"11711","DOI":"10.1074\/jbc.270.20.11711","volume":"270","author":"B Yang","year":"1995","unstructured":"Yang B, Jung D, Motto D, Meyer J, Koretzky G, Campbell KP. SH3 domain-mediated interaction of dystroglycan and Grb2. J Biol Chem. 1995;270(20):11711\u20134.","journal-title":"J Biol Chem"},{"issue":"5","key":"195_CR11","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/sj.embor.7400140","volume":"5","author":"HJ Spence","year":"2004","unstructured":"Spence HJ, Dhillon AS, James M, Winder SJ. Dystroglycan, a scaffold for the ERK-MAP kinase cascade. EMBO Rep. 2004;5(5):484\u20139.","journal-title":"EMBO Rep"},{"issue":"8","key":"195_CR12","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1053\/hupa.2001.26468","volume":"32","author":"MD Henry","year":"2001","unstructured":"Henry MD, Cohen MB, Campbell KP. Reduced expression of dystroglycan in breast and prostate cancer. Hum Pathol. 2001;32(8):791\u20135.","journal-title":"Hum Pathol"},{"issue":"3","key":"195_CR13","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0002-9440(10)63881-3","volume":"162","author":"A Sgambato","year":"2003","unstructured":"Sgambato A, Migaldi M, Montanari M, Camerini A, Brancaccio A, Rossi G, et al. Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression. Am J Pathol. 2003;162(3):849\u201360.","journal-title":"Am J Pathol"},{"issue":"17","key":"195_CR14","doi-asserted-by":"publisher","first-page":"11279","DOI":"10.1074\/jbc.C900007200","volume":"284","author":"DB de Bernabe","year":"2009","unstructured":"de Bernabe DB, Inamori K, Yoshida-Moriguchi T, Weydert CJ, Harper HA, Willer T, et al. Loss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE. J Biol Chem. 2009;284(17):11279\u201384.","journal-title":"J Biol Chem"},{"issue":"4","key":"195_CR15","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1074\/jbc.M112.432807","volume":"288","author":"AK Esser","year":"2013","unstructured":"Esser AK, Miller MR, Huang Q, Meier MM, Beltran-Valero de Bernabe D, Stipp CS, et al. Loss of LARGE2 disrupts functional glycosylation of alpha-dystroglycan in prostate cancer. J Biol Chem. 2013;288(4):2132\u201342.","journal-title":"J Biol Chem"},{"issue":"29","key":"195_CR16","doi-asserted-by":"publisher","first-page":"12109","DOI":"10.1073\/pnas.0904515106","volume":"106","author":"X Bao","year":"2009","unstructured":"Bao X, Kobayashi M, Hatakeyama S, Angata K, Gullberg D, Nakayama J, et al. Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N-acetylglucosaminyltransferase. Proc Natl Acad Sci U S A. 2009;106(29):12109\u201314.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"195_CR17","doi-asserted-by":"publisher","first-page":"416","DOI":"10.2353\/ajpath.2010.090405","volume":"176","author":"K Fernandez","year":"2010","unstructured":"Fernandez K, Serinagaoglu Y, Hammond S, Martin LT, Martin PT. Mice lacking dystrophin or alpha sarcoglycan spontaneously develop embryonal rhabdomyosarcoma with cancer-associated p53 mutations and alternatively spliced or mutant Mdm2 transcripts. Am J Pathol. 2010;176(1):416\u201334.","journal-title":"Am J Pathol"},{"issue":"11","key":"195_CR18","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.humpath.2007.03.025","volume":"38","author":"LT Martin","year":"2007","unstructured":"Martin LT, Glass M, Dosunmu E, Martin PT. Altered expression of natively glycosylated alpha dystroglycan in pediatric solid tumors. Hum Pathol. 2007;38(11):1657\u201368.","journal-title":"Hum Pathol"},{"issue":"6","key":"195_CR19","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/ng.2974","volume":"46","author":"Y Wang","year":"2014","unstructured":"Wang Y, Marino-Enriquez A, Bennett RR, Zhu M, Shen Y, Eilers G, et al. Dystrophin is a tumor suppressor in human cancers with myogenic programs. Nat Genet. 2014;46(6):601\u20136.","journal-title":"Nat Genet"},{"issue":"51","key":"195_CR20","doi-asserted-by":"publisher","first-page":"6550","DOI":"10.1038\/onc.2008.255","volume":"27","author":"E Taniguchi","year":"2008","unstructured":"Taniguchi E, Nishijo K, McCleish AT, Michalek JE, Grayson MH, Infante AJ, et al. PDGFR-A is a therapeutic target in alveolar rhabdomyosarcoma. Oncogene. 2008;27(51):6550\u201360.","journal-title":"Oncogene"},{"issue":"17","key":"195_CR21","doi-asserted-by":"publisher","first-page":"6383","DOI":"10.1073\/pnas.1403608111","volume":"111","author":"MI Aslam","year":"2014","unstructured":"Aslam MI, Abraham J, Mansoor A, Druker BJ, Tyner JW, Keller C. PDGFRbeta reverses EphB4 signaling in alveolar rhabdomyosarcoma. Proc Natl Acad Sci U S A. 2014;111(17):6383\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"195_CR22","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/nchembio.2146","volume":"12","author":"DC Briggs","year":"2016","unstructured":"Briggs DC, Yoshida-Moriguchi T, Zheng T, Venzke D, Anderson ME, Strazzulli A, Moracci M, Yu L, Hohenester E, Campbell KP. Structural basis of laminin binding to the LARGE glycans on dystroglycan. Nat Chem Biol. 2016;12(10):810\u20134.","journal-title":"Nat Chem Biol"},{"issue":"6896","key":"195_CR23","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nature00837","volume":"418","author":"DE Michele","year":"2002","unstructured":"Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, Satz JS, Dollar H, Nishino I, Kelley RI, Somer H, Straub V, Mathews KD, Moore SA, Campbell KP. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature. 2002;418(6896):417\u201322.","journal-title":"Nature"},{"issue":"10","key":"195_CR24","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/nchembio.2146","volume":"12","author":"D Briggs","year":"2016","unstructured":"Briggs D, Yoshida-Moriguchi T, Zheng T, Venzke D, Anderson M, Strazzulli A, Moracci M, Yu L, Hohenester E, Campbell KP. Structural basis of laminin binding to the LARGE glycans on dystroglycan. Nat Chem Biol. 2016;12(10):810\u20134.","journal-title":"Nat Chem Biol"},{"issue":"7474","key":"195_CR25","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/nature12605","volume":"503","author":"MM Goddeeris","year":"2013","unstructured":"Goddeeris MM, Wu B, Venzke D, Yoshida-Moriguchi T, Saito F, Matsumura K, et al. LARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy. Nature. 2013;503(7474):136\u201340.","journal-title":"Nature."},{"issue":"2","key":"195_CR26","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1158\/2159-8290.CD-13-0639","volume":"4","author":"JF Shern","year":"2014","unstructured":"Shern JF, Chen L, Chmielecki J, Wei JS, Patidar R, Rosenberg M, et al. Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors. Cancer Discov. 2014;4(2):216\u201331.","journal-title":"Cancer Discov"},{"key":"195_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12943-015-0416-z","volume":"14","author":"MR Miller","year":"2015","unstructured":"Miller MR, Ma D, Schappet J, Breheny P, Mott SL, Bannick N, et al. Downregulation of dystroglycan glycosyltransferases LARGE2 and ISPD associate with increased mortality in clear cell renal cell carcinoma. Mol Cancer. 2015;14:141.","journal-title":"Mol Cancer"},{"issue":"3","key":"195_CR28","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/glycob\/cws152","volume":"23","author":"K Inamori","year":"2013","unstructured":"Inamori K, Hara Y, Willer T, Anderson ME, Zhu Z, Yoshida-Moriguchi T, et al. Xylosyl- and glucuronyltransferase functions of LARGE in alpha-dystroglycan modification are conserved in LARGE2. Glycobiology. 2013;23(3):295\u2013302.","journal-title":"Glycobiology."}],"container-title":["Skeletal Muscle"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13395-019-0195-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13395-019-0195-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13395-019-0195-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T19:08:03Z","timestamp":1588446483000},"score":1,"resource":{"primary":{"URL":"https:\/\/skeletalmusclejournal.biomedcentral.com\/articles\/10.1186\/s13395-019-0195-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,4]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["195"],"URL":"https:\/\/doi.org\/10.1186\/s13395-019-0195-0","relation":{},"ISSN":["2044-5040"],"issn-type":[{"value":"2044-5040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,4]]},"assertion":[{"value":"19 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Muscle biopsies were originally collected for diagnostic purposes, at which time informed consent was obtained from all subjects or their legal guardians. The biopsies were collected and tested according to the guidelines set out by the Human Subjects Institutional Review Board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"11"}}